Orofacial Pain: Page 29

Physicians issue consensus on odontogenic sinusitis

By DrBicuspid.com staff writers

An international research team has issued a consensus statement on diagnosing the underrecognized infection of odontogenic sinusitis. The review was published online February 17 in the International Forum of Allergy & Rhinology.

March 23, 2021

Septodont's Novocol Pharma secures $26M

By DrBicuspid.com staff writers

Septodont's Novocol Pharma division has secured $32.7 million Canadian ($26 million U.S.) from the Canadian government to further develop its injectable products.

March 22, 2021

Dentists warn about pandemic-related bruxism

By DrBicuspid.com staff writers

Rising levels of unemployment, isolation, and other changes related to the COVID-19 pandemic may be causing more patients to experience bruxism, according to a letter to the editor published on March 12 in the British Dental Journal.

March 15, 2021

U.K. school gets $2M to study therapy for dental anxiety

By DrBicuspid.com staff writers

The University of Sheffield's School of Clinical Dentistry was awarded a grant for 1.6 million pounds ($2.2 million U.S.) to study whether cognitive behavioral therapy can reduce dental anxiety in children.

March 14, 2021

Oral damage common in COVID-19 survivors

By Theresa Pablos

More than 80% of COVID-19 survivors had damage to the oral cavity or surrounding structures in a study published on March 3 in the Journal of Dental Research. Abnormal salivary gland dilation and dry mouth were the most common conditions identified in 122 formerly hospitalized patients.

March 10, 2021

Anesthesia & Pain Management Insider: Oral damage common in COVID-19 survivors

By Theresa Pablos

March 8, 2021

What you need to know about cannabis

By Theresa Pablos

When it comes to cannabis in the dental office, there are more questions than answers. Pharmacologist Tom Viola, RPh, sat down with DrBicuspid.com to discuss what we know -- and don't know -- about the controversial green plant.

March 8, 2021

95% of opioid prescriptions are for 5 dental procedures

By Melissa Busch

Dentists wrote about 2.7 million opioid prescriptions to patients during a five-year period, according to a study published on February 23 in the Journal of the American Dental Association. About 95% of these prescriptions were written for five dental procedures.

March 4, 2021

COVID-19 pandemic spurs stress-related dental conditions

By Theresa Pablos

Dentists are seeing an increase in patients experiencing dental conditions associated with stress, such as teeth grinding, cracked teeth, and temporomandibular joint disorder symptoms, according to new poll data released by the ADA on March 2.

March 4, 2021

Searches for toothaches up during COVID-19 lockdown

By Hannah Welk

The COVID-19 lockdown increased online searches for toothaches in Iran, according to a study published on February 15 in BMC Oral Health. Pain is seen as one of the biggest dental complaints around the world.

March 4, 2021

Patterson's dental sales spike in fiscal Q3

By DrBicuspid.com staff writers

Patterson Companies reported higher sales in its dental segment for the third quarter of fiscal year 2021.

March 2, 2021

Fewer opioids prescribed in 3rd-molar surgeries with bupivacaine

By Melissa Busch

Oral surgeons prescribed 59% fewer total opioids for patients who received liposomal bupivacaine (LB) during third-molar extractions than for those who did not receive LB, according to a study published on February 22 in the Journal of Oral and Maxillofacial Surgery.

March 2, 2021

Previous Page

Page 29 of 190

Next Page